PC
INVA icon

PointState Capital’s Innoviva INVA Stock Holding History

PointState Capital’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-310,255
Closed -$10.2M – 159
2013
Q3 		$10.2M Buy
+310,255
New +$9.65M 0.18% 81

Other funds holding INVA

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PointState Capital's INVA Position: Q4 2013 in Review

PointState Capital sold out of Innoviva (INVA) in Q4 2013, closing a stake of 310,255 shares — an estimated $10.2M sold.

PointState Capital first reported a position in INVA in Q3 2013 and held it in 1 quarter. The position peaked at $10.2M in Q3 2013. 149 funds tracked by Wall St. Rank hold INVA as of Q4 2013.

  • PointState Capital reported no remaining Innoviva position as of Q4 2013 after selling out during the quarter.
  • PointState Capital sold 310,255 Innoviva shares in Q4 2013, an estimated $10.2M.
  • PointState Capital first reported a position in Innoviva in Q3 2013 and held it in 1 quarter.
  • PointState Capital's Innoviva position peaked at $10.2M in Q3 2013.
  • 149 funds tracked by Wall St. Rank held Innoviva as of Q4 2013.

Based on PointState Capital's 13F filing for Q4 2013, filed 14 Feb 2014.